Does GUSELKUMAB Cause Therapy cessation? 152 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Therapy cessation have been filed in association with GUSELKUMAB (TREMFYA). This represents 0.5% of all adverse event reports for GUSELKUMAB.
152
Reports of Therapy cessation with GUSELKUMAB
0.5%
of all GUSELKUMAB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Therapy cessation From GUSELKUMAB?
Of the 152 reports, 14 (9.2%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GUSELKUMAB. However, 152 reports have been filed with the FAERS database.
What Other Side Effects Does GUSELKUMAB Cause?
Product dose omission issue (9,267)
Accidental exposure to product (2,941)
Drug ineffective (1,971)
Needle issue (1,933)
Psoriasis (1,817)
Device issue (1,613)
Device malfunction (1,410)
Off label use (1,186)
Product storage error (1,017)
Inappropriate schedule of product administration (830)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which GUSELKUMAB Alternatives Have Lower Therapy cessation Risk?
GUSELKUMAB vs HAIR KERATIN AMINO ACIDS GOLD COMPLEX
GUSELKUMAB vs HALDOL
GUSELKUMAB vs HALOBETASOL
GUSELKUMAB vs HALOPERIDOL
GUSELKUMAB vs HALOPERIDOL DECANOATE